Tongue swabs could soon replace painful sputum hacks in the global fight against TB, unlocking faster diagnoses where millions die waiting.
Story Highlights
- WHO endorses near-point-of-care molecular tests for initial TB detection at community clinics, bypassing central labs.
- Tongue swabs offer simple sample collection for adults and adolescents unable to produce sputum.
- Sputum pooling cuts costs and boosts efficiency in high-burden, low-resource areas.
- These first-time recommendations target diagnostic delays under the End TB Strategy.
- Full guidelines and toolkits roll out in 2026 to speed global implementation.
WHO Announces Game-Changing TB Diagnostic Updates
On March 9, 2026, WHO released updated guidelines recommending near-point-of-care (NPOC) molecular tests, known as NPOC-NAATs, for detecting TB without rifampicin resistance at peripheral health centers. These tests deliver results in hours, enabling immediate treatment starts. Dr. Tereza Kasaeva, WHO’s Director for HIV/TB/Hepatitis/STIs, called this a major advance in accessibility. Countries now prepare to integrate these tools into national programs.
NEWS RELEASE: WHO recommends new diagnostic tools to help end TB https://t.co/kAwy80lMB1
— vijay banga (@kuku27) March 24, 2026
Tongue Swabs Transform Sample Collection for Vulnerable Patients
Tongue swabs emerge as a breakthrough for adults and adolescents who cannot produce sputum, a common barrier in TB diagnosis. Health workers simply swab the tongue, making testing painless and feasible in field settings. This innovation targets people living with HIV, children, and others in high-burden regions. Evidence from Liverpool School of Tropical Medicine’s Start4All project validates their reliability and ease.
Sputum Pooling Delivers Cost Savings and Scale
Sputum pooling combines samples from multiple patients for initial testing, slashing costs by up to 50% in resource-limited clinics. Positive pools trigger individual tests, optimizing scarce reagents. LSTM research proves this method maintains accuracy while expanding reach. WHO urges national programs to adopt pooling immediately, aligning with End TB Strategy goals for universal access.
Evolution from Lab-Centric to Decentralized Testing
TB diagnostics progressed from basic sputum microscopy to advanced molecular tests like LC-aNAATs over decades. The 2014 End TB Strategy set ambitious targets, but sputum dependency and lab centralization caused delays affecting millions annually. Prior guidelines in 2021 introduced chest X-ray with CAD and 2025 unified modules on infection and resistance. New evidence post-2025 drove these peripheral shifts.
Stakeholders Drive Rapid Rollout
WHO leads with GRADE-assessed evidence, collaborating with LSTM for data on swabs and pooling. National TB programs implement via upcoming toolkits and webinars. Guideline Development Groups evaluate ongoing innovations like AI cough analysis. Dr. Kasaeva pushes countries to consult WHO before adoption.
Impacts Promise End TB Progress
Short-term gains include quicker peripheral testing and easier access, reducing delays that fuel transmission. Long-term, these tools cut incidence and mortality toward 2035 targets. High-burden communities, PLHIV, and children benefit most through decentralization. Economic efficiencies from pooling free budgets for treatment scale-up. Political momentum strengthens UN commitments, pressuring global action.
Sources:
WHO recommends near point-of-care tests, tongue swabs, and sputum pooling for TB diagnosis
Public call for data to inform WHO policy updates on tools for screening for TB disease
WHO launches an update on the consolidated guidelines to diagnose TB
WHO releases new TB diagnostic guidelines
LSTM research informs new WHO guidelines on expanding access to TB diagnosis
Tuberculosis diagnostics in the 21st century
WHO introduces new TB testing recommendations including tongue swabs and rapid molecular tests
